DaVita runs kidney dialysis clinics across the US.
DaVita Inc. (DVA) is expected to report earnings on Wednesday, October 28, 2026, after the close. Estimated release time 16:08 ET. Consensus EPS estimate is $3.58.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | FY2026 Q2 | $3.88 | $4.10 | +5.7% | $3.55B |
| 2026-05-05 | FY2026 Q1 | $2.41 | $2.93 | +21.6% | $3.42B |
| 2026-02-02 | FY2025 Q4 | $3.24 | $2.51 | -22.5% | $3.62B |
| 2025-10-29 | FY2025 Q3 | $3.17 | $2.09 | -34.1% | $3.42B |
| 2025-08-05 | FY2025 Q2 | $2.70 | $2.62 | -3.0% | $3.38B |
| 2025-05-12 | FY2025 Q1 | $1.95 | $2.05 | +5.1% | $3.22B |
| 2025-02-13 | FY2024 Q4 | $2.14 | $3.18 | +48.6% | $3.29B |
| 2024-10-29 | FY2024 Q3 | $2.72 | $2.56 | -5.9% | $3.26B |
DVA has beaten consensus EPS in 4 of its last 8 reported quarters.
Highlights from DVA's Aug 4 report: EPS of $4.10 — a beat vs the $3.88 estimate (+6%); revenue of $3.55B — in line with the $3.50B consensus. Focus now shifts to treatment volumes and GLP-1 narrative.
See DVA on the live calendar →